Subsequently, a huge mendelian randomization meta-analysis by Wensley and colleagues [39] clearly showed that CRP levels genetically determined by CRP polymorphisms including rs1205 are unrelated to CAD risk. The gene discussed is CRP; the disease is coronary artery disorder.